taxonomy (1)
protein (6)
source (5)
structure (2)
composition (210)
disease (1)
reference (5)
site (94)
peptide (231)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
- Recombinant Spike glycoprotein (FreeStyle 293-F) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
- Recombinant Spike glycoprotein (HEK293-F) - ectodomain trimer / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
- Recombinant Spike glycoprotein (Schneider 2) - ectodomain trimer / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
- Recombinant Spike glycoprotein (Schneider 2) - Receptor-binding domain monomer / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
Protein
- BTI-Tn-5B1-4 (CVCL_C190)
- FreeStyle 293-F (CVCL_D603)
- HEK293 (CVCL_0045)
- HEK293-F (CVCL_6642)
- Schneider 2 (CVCL_Z232)
Source
- O-Linked / Core 0 / GalNAc
- O-Linked / Core 1 / Gal(b1-3)GalNAc
Reported structure
- HexNAc:1 (avg mass : 221.2103 )
- HexNAc:1 dHex:1 (avg mass : 367.3533 )
- HexNAc:1 dHex:2 (avg mass : 513.4963 )
- HexNAc:2 (avg mass : 424.4053 )
- HexNAc:2 dHex:1 (avg mass : 570.5483 )
- HexNAc:2 dHex:2 (avg mass : 716.6913 )
- Hex:1 HexNAc:1 (avg mass : 383.3527 )
- Hex:1 HexNAc:1 NeuAc:2 (avg mass : 965.8685 )
- Hex:1 HexNAc:2 (avg mass : 586.5477 )
- Hex:1 HexNAc:2 dHex:1 (avg mass : 732.6907 )
- Hex:1 HexNAc:2 dHex:2 (avg mass : 878.8337 )
- Hex:2 HexNAc:2 (avg mass : 748.6901 )
- Hex:2 HexNAc:2 NeuAc:1 (avg mass : 1039.948 )
- Hex:2 HexNAc:2 NeuAc:2 (avg mass : 1331.2059 )
- Hex:2 HexNAc:2 dHex:1 (avg mass : 894.8331 )
- Hex:2 HexNAc:2 dHex:2 (avg mass : 1040.9761 )
- Hex:2 HexNAc:3 (avg mass : 951.8851 )
- Hex:2 HexNAc:3 dHex:1 (avg mass : 1098.0281 )
- Hex:2 HexNAc:3 dHex:2 (avg mass : 1244.1711 )
- Hex:2 HexNAc:5 (avg mass : 1358.2751 )
- Hex:3 HexNAc:2 (avg mass : 910.8325 )
- Hex:3 HexNAc:2 dHex:1 (avg mass : 1056.9755 )
- Hex:3 HexNAc:2 dHex:2 (avg mass : 1203.1185 )
- Hex:3 HexNAc:3 (avg mass : 1114.0275 )
- Hex:3 HexNAc:3 dHex:1 (avg mass : 1260.1705 )
- Hex:3 HexNAc:3 dHex:2 (avg mass : 1406.3135 )
- Hex:3 HexNAc:4 (avg mass : 1317.2225 )
- Hex:3 HexNAc:4 NeuAc:1 (avg mass : 1608.4804 )
- Hex:3 HexNAc:4 dHex:1 (avg mass : 1463.3655 )
- Hex:3 HexNAc:4 dHex:2 (avg mass : 1609.5085 )
- Hex:3 HexNAc:4 dHex:3 (avg mass : 1755.6515 )
- Hex:3 HexNAc:5 (avg mass : 1520.4175 )
- Hex:3 HexNAc:5 dHex:1 (avg mass : 1666.5605 )
- Hex:3 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 1957.8184 )
- Hex:3 HexNAc:6 (avg mass : 1723.6125 )
- Hex:3 HexNAc:6 dHex:1 (avg mass : 1869.7555 )
- Hex:3 HexNAc:6 dHex:1 NeuAc:1 (avg mass : 2161.0134 )
- Hex:3 HexNAc:6 dHex:1 NeuAc:2 (avg mass : 2452.2713 )
- Hex:3 HexNAc:6 dHex:2 (avg mass : 2015.8985 )
- Hex:3 HexNAc:6 dHex:3 (avg mass : 2162.0415 )
- Hex:3 HexNAc:7 (avg mass : 1926.8075 )
- Hex:3 HexNAc:7 dHex:1 (avg mass : 2072.9505 )
- Hex:3 HexNAc:8 (avg mass : 2130.0025 )
- Hex:3 HexNAc:8 dHex:1 (avg mass : 2276.1455 )
- Hex:3 HexNAc:9 (avg mass : 2333.1975 )
- Hex:3 HexNAc:9 dHex:1 (avg mass : 2479.3405 )
- Hex:4 HexNAc:2 (avg mass : 1072.9749 )
- Hex:4 HexNAc:2 dHex:1 (avg mass : 1219.1179 )
- Hex:4 HexNAc:2 dHex:2 (avg mass : 1365.2609 )
- Hex:4 HexNAc:3 (avg mass : 1276.1699 )
- Hex:4 HexNAc:3 NeuAc:1 (avg mass : 1567.4278 )
- Hex:4 HexNAc:3 dHex:1 (avg mass : 1422.3129 )
- Hex:4 HexNAc:3 dHex:1 NeuAc:1 (avg mass : 1713.5708 )
- Hex:4 HexNAc:3 dHex:2 (avg mass : 1568.4559 )
- Hex:4 HexNAc:3 dHex:3 (avg mass : 1714.5989 )
- Hex:4 HexNAc:4 (avg mass : 1479.3649 )
- Hex:4 HexNAc:4 NeuAc:1 (avg mass : 1770.6228 )
- Hex:4 HexNAc:4 dHex:1 (avg mass : 1625.5079 )
- Hex:4 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 1916.7658 )
- Hex:4 HexNAc:4 dHex:2 (avg mass : 1771.6509 )
- Hex:4 HexNAc:5 (avg mass : 1682.5599 )
- Hex:4 HexNAc:5 NeuAc:1 (avg mass : 1973.8178 )
- Hex:4 HexNAc:5 NeuAc:2 (avg mass : 2265.0757 )
- Hex:4 HexNAc:5 dHex:1 (avg mass : 1828.7029 )
- Hex:4 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2119.9608 )
- Hex:4 HexNAc:5 dHex:1 NeuAc:2 (avg mass : 2411.2187 )
- Hex:4 HexNAc:5 dHex:2 (avg mass : 1974.8459 )
- Hex:4 HexNAc:5 dHex:2 NeuAc:1 (avg mass : 2266.1038 )
- Hex:4 HexNAc:6 (avg mass : 1885.7549 )
- Hex:4 HexNAc:6 NeuAc:1 (avg mass : 2177.0128 )
- Hex:4 HexNAc:6 dHex:1 (avg mass : 2031.8979 )
- Hex:4 HexNAc:6 dHex:2 (avg mass : 2178.0409 )
- Hex:4 HexNAc:6 dHex:4 (avg mass : 2470.3269 )
- Hex:4 HexNAc:7 (avg mass : 2088.9499 )
- Hex:4 HexNAc:7 dHex:1 (avg mass : 2235.0929 )
- Hex:4 HexNAc:7 dHex:2 (avg mass : 2381.2359 )
- Hex:4 HexNAc:7 dHex:3 (avg mass : 2527.3789 )
- Hex:4 HexNAc:8 (avg mass : 2292.1449 )
- Hex:4 HexNAc:9 (avg mass : 2495.3399 )
- Hex:4 HexNAc:9 dHex:1 (avg mass : 2641.4829 )
- Hex:5 HexNAc:2 (avg mass : 1235.1173 )
- Hex:5 HexNAc:2 dHex:1 (avg mass : 1381.2603 )
- Hex:5 HexNAc:2 dHex:2 (avg mass : 1527.4033 )
- Hex:5 HexNAc:3 (avg mass : 1438.3123 )
- Hex:5 HexNAc:3 NeuAc:1 (avg mass : 1729.5702 )
- Hex:5 HexNAc:3 dHex:1 (avg mass : 1584.4553 )
- Hex:5 HexNAc:3 dHex:2 (avg mass : 1730.5983 )
- Hex:5 HexNAc:4 (avg mass : 1641.5073 )
- Hex:5 HexNAc:4 NeuAc:1 (avg mass : 1932.7652 )
- Hex:5 HexNAc:4 NeuAc:2 (avg mass : 2224.0231 )
- Hex:5 HexNAc:4 dHex:1 (avg mass : 1787.6503 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2078.9082 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 (avg mass : 2370.1661 )
- Hex:5 HexNAc:4 dHex:2 (avg mass : 1933.7933 )
- Hex:5 HexNAc:4 dHex:2 NeuAc:1 (avg mass : 2225.0512 )
- Hex:5 HexNAc:4 dHex:3 (avg mass : 2079.9363 )
- Hex:5 HexNAc:4 dHex:3 NeuAc:1 (avg mass : 2371.1942 )
- Hex:5 HexNAc:4 dHex:4 (avg mass : 2226.0793 )
- Hex:5 HexNAc:4 dHex:5 (avg mass : 2372.2223 )
- Hex:5 HexNAc:5 (avg mass : 1844.7023 )
- Hex:5 HexNAc:5 NeuAc:1 (avg mass : 2135.9602 )
- Hex:5 HexNAc:5 NeuAc:2 (avg mass : 2427.2181 )
- Hex:5 HexNAc:5 dHex:1 (avg mass : 1990.8453 )
- Hex:5 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2282.1032 )
- Hex:5 HexNAc:5 dHex:1 NeuAc:2 (avg mass : 2573.3611 )
- Hex:5 HexNAc:5 dHex:2 (avg mass : 2136.9883 )
- Hex:5 HexNAc:5 dHex:3 (avg mass : 2283.1313 )
- Hex:5 HexNAc:6 (avg mass : 2047.8973 )
- Hex:5 HexNAc:6 dHex:1 (avg mass : 2194.0403 )
- Hex:5 HexNAc:6 dHex:1 NeuAc:1 (avg mass : 2485.2982 )
- Hex:5 HexNAc:6 dHex:1 NeuAc:2 (avg mass : 2776.5561 )
- Hex:5 HexNAc:6 dHex:1 NeuAc:3 (avg mass : 3067.814 )
- Hex:5 HexNAc:6 dHex:2 (avg mass : 2340.1833 )
- Hex:5 HexNAc:8 dHex:1 (avg mass : 2600.4303 )
- Hex:6 HexNAc:2 (avg mass : 1397.2597 )
- Hex:6 HexNAc:3 (avg mass : 1600.4547 )
- Hex:6 HexNAc:3 NeuAc:1 (avg mass : 1891.7126 )
- Hex:6 HexNAc:3 dHex:1 (avg mass : 1746.5977 )
- Hex:6 HexNAc:3 dHex:1 NeuAc:1 (avg mass : 2037.8556 )
- Hex:6 HexNAc:4 (avg mass : 1803.6497 )
- Hex:6 HexNAc:4 NeuAc:1 (avg mass : 2094.9076 )
- Hex:6 HexNAc:4 dHex:1 (avg mass : 1949.7927 )
- Hex:6 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2241.0506 )
- Hex:6 HexNAc:4 dHex:2 (avg mass : 2095.9357 )
- Hex:6 HexNAc:4 dHex:3 (avg mass : 2242.0787 )
- Hex:6 HexNAc:5 (avg mass : 2006.8447 )
- Hex:6 HexNAc:5 NeuAc:1 (avg mass : 2298.1026 )
- Hex:6 HexNAc:5 NeuAc:2 (avg mass : 2589.3605 )
- Hex:6 HexNAc:5 NeuAc:3 (avg mass : 2880.6184 )
- Hex:6 HexNAc:5 dHex:1 (avg mass : 2152.9877 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2444.2456 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:2 (avg mass : 2735.5035 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:3 (avg mass : 3026.7614 )
- Hex:6 HexNAc:5 dHex:2 (avg mass : 2299.1307 )
- Hex:6 HexNAc:5 dHex:2 NeuAc:1 (avg mass : 2590.3886 )
- Hex:6 HexNAc:5 dHex:3 NeuAc:1 (avg mass : 2736.5316 )
- Hex:6 HexNAc:6 (avg mass : 2210.0397 )
- Hex:6 HexNAc:6 NeuAc:1 (avg mass : 2501.2976 )
- Hex:6 HexNAc:6 NeuAc:2 (avg mass : 2792.5555 )
- Hex:6 HexNAc:6 dHex:1 (avg mass : 2356.1827 )
- Hex:6 HexNAc:6 dHex:1 NeuAc:1 (avg mass : 2647.4406 )
- Hex:6 HexNAc:6 dHex:1 NeuAc:2 (avg mass : 2938.6985 )
- Hex:6 HexNAc:6 dHex:1 NeuAc:3 (avg mass : 3229.9564 )
- Hex:6 HexNAc:6 dHex:2 (avg mass : 2502.3257 )
- Hex:6 HexNAc:6 dHex:3 (avg mass : 2648.4687 )
- Hex:6 HexNAc:7 (avg mass : 2413.2347 )
- Hex:6 HexNAc:7 dHex:1 (avg mass : 2559.3777 )
- Hex:6 HexNAc:7 dHex:1 NeuAc:4 (avg mass : 3724.4093 )
- Hex:6 HexNAc:8 (avg mass : 2616.4297 )
- Hex:6 HexNAc:9 (avg mass : 2819.6247 )
- Hex:7 HexNAc:2 (avg mass : 1559.4021 )
- Hex:7 HexNAc:3 (avg mass : 1762.5971 )
- Hex:7 HexNAc:4 (avg mass : 1965.7921 )
- Hex:7 HexNAc:4 NeuAc:1 (avg mass : 2257.05 )
- Hex:7 HexNAc:4 dHex:1 (avg mass : 2111.9351 )
- Hex:7 HexNAc:4 dHex:3 (avg mass : 2404.2211 )
- Hex:7 HexNAc:5 (avg mass : 2168.9871 )
- Hex:7 HexNAc:5 dHex:1 (avg mass : 2315.1301 )
- Hex:7 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2606.388 )
- Hex:7 HexNAc:5 dHex:1 NeuAc:2 (avg mass : 2897.6459 )
- Hex:7 HexNAc:5 dHex:2 (avg mass : 2461.2731 )
- Hex:7 HexNAc:6 (avg mass : 2372.1821 )
- Hex:7 HexNAc:6 NeuAc:1 (avg mass : 2663.44 )
- Hex:7 HexNAc:6 NeuAc:2 (avg mass : 2954.6979 )
- Hex:7 HexNAc:6 NeuAc:3 (avg mass : 3245.9558 )
- Hex:7 HexNAc:6 NeuAc:4 (avg mass : 3537.2137 )
- Hex:7 HexNAc:6 dHex:1 (avg mass : 2518.3251 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:1 (avg mass : 2809.583 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:2 (avg mass : 3100.8409 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:3 (avg mass : 3392.0988 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:4 (avg mass : 3683.3567 )
- Hex:7 HexNAc:6 dHex:4 NeuAc:1 (avg mass : 3248.012 )
- Hex:7 HexNAc:6 dHex:4 NeuAc:2 (avg mass : 3539.2699 )
- Hex:7 HexNAc:6 dHex:5 NeuAc:4 (avg mass : 4267.9287 )
- Hex:7 HexNAc:7 dHex:1 (avg mass : 2721.5201 )
- Hex:7 HexNAc:7 dHex:1 NeuAc:2 (avg mass : 3304.0359 )
- Hex:7 HexNAc:7 dHex:1 NeuAc:3 (avg mass : 3595.2938 )
- Hex:7 HexNAc:7 dHex:1 NeuAc:4 (avg mass : 3886.5517 )
- Hex:7 HexNAc:7 dHex:3 (avg mass : 3013.8061 )
- Hex:7 HexNAc:8 (avg mass : 2778.5721 )
- Hex:8 HexNAc:2 (avg mass : 1721.5445 )
- Hex:8 HexNAc:5 (avg mass : 2331.1295 )
- Hex:8 HexNAc:6 (avg mass : 2534.3245 )
- Hex:8 HexNAc:6 NeuAc:1 (avg mass : 2825.5824 )
- Hex:8 HexNAc:6 dHex:1 NeuAc:1 (avg mass : 2971.7254 )
- Hex:8 HexNAc:7 (avg mass : 2737.5195 )
- Hex:8 HexNAc:7 NeuAc:1 (avg mass : 3028.7774 )
- Hex:8 HexNAc:7 dHex:1 (avg mass : 2883.6625 )
- Hex:8 HexNAc:7 dHex:1 NeuAc:1 (avg mass : 3174.9204 )
- Hex:8 HexNAc:7 dHex:1 NeuAc:2 (avg mass : 3466.1783 )
- Hex:8 HexNAc:7 dHex:1 NeuAc:3 (avg mass : 3757.4362 )
- Hex:8 HexNAc:7 dHex:1 NeuAc:4 (avg mass : 4048.6941 )
- Hex:8 HexNAc:8 (avg mass : 2940.7145 )
- Hex:8 HexNAc:8 dHex:1 (avg mass : 3086.8575 )
- Hex:9 HexNAc:2 (avg mass : 1883.6869 )
- Hex:9 HexNAc:4 dHex:1 (avg mass : 2436.2199 )
- Hex:9 HexNAc:5 dHex:1 (avg mass : 2639.4149 )
- Hex:9 HexNAc:6 (avg mass : 2696.4669 )
- Hex:9 HexNAc:6 dHex:1 NeuAc:2 (avg mass : 3425.1257 )
- Hex:9 HexNAc:8 (avg mass : 3102.8569 )
- Hex:9 HexNAc:8 dHex:1 (avg mass : 3248.9999 )
- Hex:9 HexNAc:8 dHex:1 NeuAc:3 (avg mass : 4122.7736 )
- Hex:9 HexNAc:8 dHex:1 NeuAc:4 (avg mass : 4414.0315 )
- Hex:9 HexNAc:9 dHex:1 (avg mass : 3452.1949 )
- Hex:10 HexNAc:2 (avg mass : 2045.8293 )
- Hex:10 HexNAc:6 dHex:1 NeuAc:1 (avg mass : 3296.0102 )
- Hex:10 HexNAc:9 (avg mass : 3468.1943 )
- Hex:10 HexNAc:9 dHex:1 (avg mass : 3614.3373 )
- Hex:11 HexNAc:2 (avg mass : 2207.9717 )
- Hex:11 HexNAc:6 dHex:1 (avg mass : 3166.8947 )
Composition
- COVID-19 (DOID:0080600)
Disease
- Site-specific O-glycosylation analysis of SARS-CoV-2 spike protein produced in insect and human cells (2021 - Ieva Bagdonaite, Andrew J. Thompson, Xiaoning Wang, Max Søgaard, Cyrielle Fougeroux, Martin Frank, Jolene K. Diedrich, John R. Yates 3rd, Ali Salanti, Sergey Y. Vakhrushev, James C. Paulson, Hans H. Wandall) / Status : Reviewed
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Unreviewed
- Deducing the N- and O- glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2 (2020 - Asif Shajahan, Nitin T. Supekar, Anne S. Gleinich, Parastoo Azadi) / Status : Reviewed
- Identification of 22 N-glycosites on spike glycoprotein of SARS-CoV-2 and accessible surface glycopeptide motifs: Implications for vaccination and antibody therapeutics (2020 - Dapeng Zhou, Xiaoxu Tian, Ruibing Qi, Chao Peng, Wen Zhang) / Status : Reviewed
- Site-specific glycan analysis of the SARS-CoV-2 spike (2020 - Yasunori Watanabe, Joel D. Allen, Daniel Wrapp, Jason S. McLellan, Max Crispin) / Status : Unreviewed
Reference
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (FreeStyle 293-F) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293-F) - ectodomain trimer / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (Schneider 2) - ectodomain trimer / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (Schneider 2) - Receptor-binding domain monomer / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Reported glycosite
- FSNVTWFHAIHVSGTNGTK (19aa)
- QCVNLTTR (8aa)
- SNVTWF (6aa)
- FSNVTWF (7aa)
- FSNVTW (6aa)
- FHAIHVSGTNGTKRF (15aa)
- FHAIHVSGTNGTK (13aa)
- FHAIHVSGTNGTKR (14aa)
- HAIHVSGTNGTKR (13aa)
- HAIHVSGTNGTKRFDNPVLPF (21aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKR (34aa)
- AIHVSGTNGTKRF (13aa)
- VTWFHAIHVSGTNGTK (16aa)
- HAIHVSGTNGTKRF (14aa)
- HAIHVSGTNGTK (12aa)
- VSGTNGTKRF (10aa)
- ASTEKSNIIRGW (12aa)
- SLLIVNNATNVVIK (14aa)
- LIVNNATNVVIK (12aa)
- SNIIRGWIFGTTLDSKTQSLLIVNNATNVVIK (32aa)
- TQSLLIVNNATNVVIKVCEFQFCNDPFLGVYYHK (34aa)
- IVNNATNVVIK (11aa)
- LIVNNATNVVIKVCEF (16aa)
- TQSLLIVNNATNVVIK (16aa)
- GWIFGTTLDSKTQSLLIVNNATNVVIK (27aa)
- TQSLLIVNNATNVVIKVCE (19aa)
- IVNNATNVVIKVCEF (15aa)
- HKNNK (5aa)
- FQFCNDPFLGVYYHKNNKSWMESE (24aa)
- FQFCNDPFLGVYYHKNNK (18aa)
- VCEFQFCNDPFLGVYYHKNNK (21aa)
- FQFCNDPFLGVYYHKNNKSWMESEF (25aa)
- VCEFQFCNDPFLGVYYHKNNKSWMESEFR (29aa)
- FQFCNDPFLGVYYHKNNKSWME (22aa)
- NNKSWMESEFR (11aa)
- YHKNNKSWMESEF (13aa)
- HKNNKSWMESEF (12aa)
- VYSSANNCTFEY (12aa)
- SSANNCTFEYVSQPF (15aa)
- SSANNCTF (8aa)
- SSANNCTFEY (10aa)
- VYSSANNCTFEYVSQPFLMDLEGK (24aa)
- SEFRVYSSANNCTFEYVSQPFLMDLE (26aa)
- VYSSANNCTFE (11aa)
- SEFRVYSSANNCTFE (15aa)
- FRVYSSANNCTFE (13aa)
- VYSSANNCTFEYVSQPFLMDLEGKQGNFKNLR (32aa)
- VYSSANNCTF (10aa)
- SALEPLVDLPIGINITRFQTL (21aa)
- VDLPIGINITR (11aa)
- SALEPLVDLPIGINITRFQTLL (22aa)
- SALEPLVDLPIGINITRF (18aa)
- GINIT (5aa)
- PLVDLPIGINITR (13aa)
- SALEPLVDLPIGINITR (17aa)
- DLPQGFSALEPLVDLPIGINITR (23aa)
- KYNENGTIT (9aa)
- FLLKYNENGTIT (12aa)
- YNENGTITDAVDCALDPLSETK (22aa)
- TFLLKYNENGTITDAVDCALDPLSETK (27aa)
- NGTITDAVDCALDPLSETK (19aa)
- NGTITDAVDCALDPLSETKCTLK (23aa)
- TFLLKYNENGTITDAVDCALDPLSE (25aa)
- NGTITDAVDCALDPLSEK (18aa)
- NGTITDAVDCALDPLSE (17aa)
- TVEKGIYQTSNF (12aa)
- RVQPTESIVR (10aa)
- VQPTESIVR (9aa)
- FPNITNLCPF (10aa)
- RVQPTESIVRFPNITNLCPFGEVF (24aa)
- VQPTESIVRFPNITN (15aa)
- FPNITNL (7aa)
- RFPNIT (6aa)
- KGIYQTSNFRVQPTESIVRFPNITNLCPFGE (31aa)
- SIVRFPNITNLCPFGE (16aa)
- FPNITNLCPFGE (12aa)
- RVQPTESIVRFPNITNL (17aa)
- RVQPTESIVRFPNITNLCPF (20aa)
- GIYQTSNFRVQPTESIVR (18aa)
- GEVFNATRF (9aa)
- GEVFNATR (8aa)
- GIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATR (36aa)
- FPNITNLCPFGEVFNATRFASVYAWNR (27aa)
- VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
- VFNATR (6aa)
- FPNITNLCPFGEVFNATR (18aa)
- NATRF (5aa)
- CPFGEVFNATR (11aa)
- GEVFNATRFASVY (13aa)
- NATRFASVY (9aa)
- VIRGDEVRQIAPGQTGKI (18aa)
- TPCNGVEGFNCY (12aa)
- HAPATVCGPKKSTNL (15aa)
- GGVSVITPGTNTSNQVAVL (19aa)
- GGVSVITPGTNTSNQVAVLY (20aa)
- VITPGTNTS (9aa)
- QDVNCTEVPVAIHADQLTPTWR (22aa)
- YQDVNCTEVPVAIHADQL (18aa)
- QDVNCTEVPVAIHADQL (17aa)
- LYQDVNCT (8aa)
- ILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWR (51aa)
- DPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWR (57aa)
- NCTEVPVAIHADQLTPTWR (19aa)
- NCTEVPVAIHADQL (14aa)
- AGCLIGAEHVNNSY (14aa)
- NNSYECDIPI (10aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRR (37aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRRAR (39aa)
- AGCLIGAEHVNNSYE (15aa)
- VYSTGSNVFQTRAGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (48aa)
- HVNNSYECDIPIGAGICASYQTQTNSPR (28aa)
- HVNNSYE (7aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSP (35aa)
- CDIPIGAGICASYQTQTNSPAR (22aa)
- QTQTNSPARAA (11aa)
- QTQTNSPARAASVASQSIIAY (21aa)
- QTQTNSPGSASSVASQ (16aa)
- QTQTNSPGSASSVASQSIIAY (21aa)
- IIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEIL (36aa)
- YSNNSIAIPT (10aa)
- YSNNSIA (7aa)
- SIIAYTMSLGAENSVAYSN (19aa)
- SNNSIAIPT (9aa)
- AYSNNSIAIPTNFTISVTTEILPVSMTK (28aa)
- SIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTK (43aa)
- IIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECSN (60aa)
- SIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTEC (59aa)
- IIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSM (40aa)
- IIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALTGIA (80aa)
- TNFTISVTTEILPVSMTK (18aa)
- NSIAIPTNFTISVTTEILPVSMTK (24aa)
- SIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGS (68aa)
- SNNSIAIPTNFTISVTTEILPVSMTK (26aa)
- NFTIS (5aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- IIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQL (72aa)
- IIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMT (41aa)
- SNNSIAIPTNF (11aa)
- NFTISVTTEILPVSMTK (17aa)
- IPTNFTISVTTEILPVSMTK (20aa)
- DFGGFNF (7aa)
- NFSQILPDPSK (11aa)
- NFNFSQILPDPSKPSKR (17aa)
- NFSQILPDPSKPSK (14aa)
- FGGFNFS (7aa)
- DFGGFNFSQILPDPSK (16aa)
- TPPIKDFGGFNFSQILPDPSKPSK (24aa)
- TPPIKDFGGFNFSQILPDPSKPSKR (25aa)
- QIYKTPPIKDFGGFNFSQILPDPSKPSK (28aa)
- DFGGFNFSQILPDPSKPSK (19aa)
- VFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIE (39aa)
- DFGGFNFSQILPDPSKPSKR (20aa)
- FGGFNFSQILPDPSKPSK (18aa)
- NFSQILPDPSKPS (13aa)
- FGGFNFSQILPDPSKPSKR (19aa)
- NFSQILPDPSKPSKR (15aa)
- NFSQILPDPSKPSKRSF (17aa)
- VPAQEKNFTTAPA (13aa)
- VPAQEKNF (8aa)
- VTYVPAQEKNFTTAPAICHDGK (22aa)
- NFTTAP (6aa)
- GYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDG (40aa)
- PAQEKNFTTAPAICHDGKAHFPR (23aa)
- VVFLHVTYVPAQEKNFTTAPAICHDGKAHFPR (32aa)
- VPAQEKNFTTAPAICH (16aa)
- HVTYVPAQEKNF (12aa)
- VPAQEKNFTTAPAICHDGKAHFPREGVF (28aa)
- NFTTAPAICHDGKAHFPREGVFVSNGTHWFVTQ (33aa)
- VPAQEKNFTTAPAICHDGK (19aa)
- CVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKAHFPRE (61aa)
- KNFTTAPAICHDGKAHFPRE (20aa)
- NFTTAPAICHDGKA (14aa)
- KNFTTAPAICHDGK (14aa)
- AQEKNFTTAPAICHDGKAHFPREGVF (26aa)
- GVFVSNGTHWFVTQR (15aa)
- AHFPREGVFVSNGTHWFVT (19aa)
- AHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPL (55aa)
- AHFPREGVFVSNGTHW (16aa)
- EGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPL (50aa)
- AHFPREGVFVSNGT (14aa)
- VSNGTHW (7aa)
- VSNGTHWF (8aa)
- EGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPE (53aa)
- EGVFVSNGTHW (11aa)
- EGVFVSNGTHWF (12aa)
- EGVFVSNGTHWFVTQRNFYEPQIITT (26aa)
- AHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVS (37aa)
- EGVFVSN (7aa)
- NGTHWFV (7aa)
- NGTHWFVT (8aa)
- GYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKAHFPR (46aa)
- VDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGK (47aa)
- AHFPREGVFVSNGTHWFVTQR (21aa)
- EGVFVSNGTHWFVTQRN (17aa)
- NFTTAPAICHDGKAHFPR (18aa)
- AHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDP (54aa)
- NFTTAPAICHDGK (13aa)
- GYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGK (41aa)
- VSNGTHWFVTQR (12aa)
- EGVFVSNGTHWFVTQRNFYEPQIITTDN (28aa)
- EGVFVSNGTHWFVTQR (16aa)
- IGIVNNT (7aa)
- IVNNT (5aa)
- KNH (3aa)
- KYFKNHTS (8aa)
- KNHTSPDVDLGDISGINASVVNIQK (25aa)
- GINASVV (7aa)
- GINAS (5aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQK (32aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- YFKNHTSPDVDLGDISGINASVVNIQK (27aa)
- NHTSPDVDLGDISGINASVVNIQKE (25aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQKE (33aa)
- NHTSPDVDLGDISGINASVVNIQKEIDR (28aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- YFKNHTSPDVDLGDISGINASVVNIQKE (28aa)
- KNLNE (5aa)
- KNLNES (6aa)
- KNLN (4aa)
- EIDRLNEVAKNLNESLIDLQELGK (24aa)
- LNEVAKNLNESLIDLQELGK (20aa)
- NLNESLIDLQELGK (14aa)
- VAKNLNE (7aa)
- IDRLNEVAKNLNESLIDLQE (20aa)
- IDRLNEVAKNLNE (13aa)
- LNEVAKNLNESLIDLQELGKYEQYIK (26aa)
- NLNESLIDLQELGKYEQYIK (20aa)
- NLNESLIDLQE (11aa)
- VAKNLNESLIDLQE (14aa)
Mass spectrometry observed peptide
-
- O-Linked / Core 0
(avg mass : 221.2103)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293-F) - ectodomain trimer / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (Schneider 2) - ectodomain trimer / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (Schneider 2) - Receptor-binding domain monomer / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- FSNVTWFHAIHVSGTNGTK (19aa)
- FHAIHVSGTNGTKRF (15aa)
- HAIHVSGTNGTK (12aa)
- HAIHVSGTNGTKRF (14aa)
- VTWFHAIHVSGTNGTK (16aa)
- VSGTNGTKRF (10aa)
- ASTEKSNIIRGW (12aa)
- IVNNATNVVIKVCEF (15aa)
- YHKNNKSWMESEF (13aa)
- HKNNKSWMESEF (12aa)
- TVEKGIYQTSNF (12aa)
- RVQPTESIVR (10aa)
- RVQPTESIVRFPNITNL (17aa)
- RVQPTESIVRFPNITNLCPF (20aa)
- GIYQTSNFRVQPTESIVR (18aa)
- GEVFNATRFASVY (13aa)
- NATRFASVY (9aa)
- HAPATVCGPKKSTNL (15aa)
- CDIPIGAGICASYQTQTNSPAR (22aa)
- QTQTNSPARAA (11aa)
- FGGFNFSQILPDPSKPSKR (19aa)
- NFSQILPDPSKPS (13aa)
- NFSQILPDPSKPSKR (15aa)
- FGGFNFSQILPDPSKPSK (18aa)
- NFSQILPDPSKPSKRSF (17aa)
- KNFTTAPAICHDGK (14aa)
- AQEKNFTTAPAICHDGKAHFPREGVF (26aa)
- GVFVSNGTHWFVTQR (15aa)
- EGVFVSNGTHWFVTQR (16aa)
-
- O-Linked / Core 1
(avg mass : 383.3527)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293-F) - ectodomain trimer / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (Schneider 2) - ectodomain trimer / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (Schneider 2) - Receptor-binding domain monomer / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- AIHVSGTNGTKRF (13aa)
- HAIHVSGTNGTK (12aa)
- VTWFHAIHVSGTNGTK (16aa)
- HAIHVSGTNGTKRF (14aa)
- RVQPTESIVRFPNITNL (17aa)
- VIRGDEVRQIAPGQTGKI (18aa)
- TPCNGVEGFNCY (12aa)
- NCTEVPVAIHADQLTPTWR (19aa)
- NCTEVPVAIHADQL (14aa)
- QTQTNSPARAASVASQSIIAY (21aa)
- QTQTNSPGSASSVASQ (16aa)
- QTQTNSPGSASSVASQSIIAY (21aa)
- KNFTTAPAICHDGK (14aa)
- EGVFVSNGTHWFVTQR (16aa)
-
- HexNAc:1 / N-Linked
(avg mass : 221.2103)
- BTI-Tn-5B1-4 (CVCL_C190)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- TQSLLIVNNATNVVIK (16aa)
- SEFRVYSSANNCTFE (15aa)
- NGTITDAVDCALDPLSE (17aa)
- FPNITNLCPFGE (12aa)
- FPNITNLCPFGEVFNATRFASVYAWNR (27aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- TPPIKDFGGFNFSQILPDPSKPSKR (25aa)
- DFGGFNFSQILPDPSKPSKR (20aa)
- DFGGFNFSQILPDPSKPSK (19aa)
- DFGGFNFSQILPDPSK (16aa)
- KNFTTAPAICHDGK (14aa)
- GVFVSNGTHWFVTQR (15aa)
- NFTTAPAICHDGK (13aa)
- EGVFVSNGTHWFVTQR (16aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- VAKNLNESLIDLQE (14aa)
-
- HexNAc:1 dHex:1 / N-Linked
(avg mass : 367.3533)
- BTI-Tn-5B1-4 (CVCL_C190)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- TQSLLIVNNATNVVIK (16aa)
- SEFRVYSSANNCTFE (15aa)
- NGTITDAVDCALDPLSE (17aa)
- FPNITNLCPFGE (12aa)
- AGCLIGAEHVNNSYE (15aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- KNFTTAPAICHDGK (14aa)
- GVFVSNGTHWFVTQR (15aa)
- NFTTAPAICHDGK (13aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQKE (33aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- NHTSPDVDLGDISGINASVVNIQKE (25aa)
- VAKNLNESLIDLQE (14aa)
-
- HexNAc:2 / N-Linked
(avg mass : 424.4053)
- BTI-Tn-5B1-4 (CVCL_C190)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKR (34aa)
- TQSLLIVNNATNVVIK (16aa)
- SEFRVYSSANNCTFE (15aa)
- NGTITDAVDCALDPLSE (17aa)
- VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
- GIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATR (36aa)
- FPNITNLCPFGEVFNATR (18aa)
- ILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWR (51aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- DFGGFNFSQILPDPSKPSKR (20aa)
- KNFTTAPAICHDGK (14aa)
- GVFVSNGTHWFVTQR (15aa)
- GYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGK (41aa)
- NFTTAPAICHDGK (13aa)
- EGVFVSNGTHWFVTQR (16aa)
- VAKNLNESLIDLQE (14aa)
-
- HexNAc:1 dHex:2 / N-Linked
(avg mass : 513.4963)
- BTI-Tn-5B1-4 (CVCL_C190)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKR (34aa)
- SEFRVYSSANNCTFE (15aa)
- NGTITDAVDCALDPLSE (17aa)
- FPNITNLCPFGEVFNATR (18aa)
- ILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWR (51aa)
- AGCLIGAEHVNNSYE (15aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- KNFTTAPAICHDGK (14aa)
- VDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGK (47aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- NHTSPDVDLGDISGINASVVNIQKE (25aa)
- NLNESLIDLQELGK (14aa)
- VAKNLNESLIDLQE (14aa)
-
- HexNAc:2 dHex:1 / N-Linked
(avg mass : 570.5483)
- BTI-Tn-5B1-4 (CVCL_C190)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKR (34aa)
- TQSLLIVNNATNVVIK (16aa)
- VYSSANNCTFE (11aa)
- SEFRVYSSANNCTFE (15aa)
- NGTITDAVDCALDPLSE (17aa)
- VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
- AGCLIGAEHVNNSYE (15aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- DFGGFNFSQILPDPSKPSKR (20aa)
- YFKNHTSPDVDLGDISGINASVVNIQK (27aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- VAKNLNESLIDLQE (14aa)
-
- Hex:1 HexNAc:2 / N-Linked
(avg mass : 586.5477)
- BTI-Tn-5B1-4 (CVCL_C190)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Unreviewed
- Identification of 22 N-glycosites on spike glycoprotein of SARS-CoV-2 and accessible surface glycopeptide motifs: Implications for vaccination and antibody therapeutics (2020 - Dapeng Zhou, Xiaoxu Tian, Ruibing Qi, Chao Peng, Wen Zhang) / Status : Reviewed
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKR (34aa)
- TQSLLIVNNATNVVIK (16aa)
- VYSSANNCTFE (11aa)
- SEFRVYSSANNCTFE (15aa)
- VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
- GIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATR (36aa)
- FPNITNLCPFGEVFNATR (18aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- TPPIKDFGGFNFSQILPDPSKPSKR (25aa)
- DFGGFNFSQILPDPSKPSKR (20aa)
- KNFTTAPAICHDGK (14aa)
- GVFVSNGTHWFVTQR (15aa)
- GYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGK (41aa)
- EGVFVSNGTHW (11aa)
- GYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKAHFPR (46aa)
- NFTTAPAICHDGK (13aa)
- EGVFVSNGTHWFVTQR (16aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- VAKNLNESLIDLQE (14aa)
-
- HexNAc:2 dHex:2 / N-Linked
(avg mass : 716.6913)
- BTI-Tn-5B1-4 (CVCL_C190)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKR (34aa)
- SEFRVYSSANNCTFE (15aa)
- VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- AGCLIGAEHVNNSYE (15aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQK (32aa)
- YFKNHTSPDVDLGDISGINASVVNIQK (27aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- NHTSPDVDLGDISGINASVVNIQKE (25aa)
- VAKNLNESLIDLQE (14aa)
-
- Hex:1 HexNAc:2 dHex:1 / N-Linked
(avg mass : 732.6907)
- BTI-Tn-5B1-4 (CVCL_C190)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKR (34aa)
- TQSLLIVNNATNVVIK (16aa)
- SEFRVYSSANNCTFE (15aa)
- NGTITDAVDCALDPLSE (17aa)
- VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
- GIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATR (36aa)
- FPNITNLCPFGEVFNATR (18aa)
- ILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWR (51aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- DFGGFNFSQILPDPSKPSK (19aa)
- GVFVSNGTHWFVTQR (15aa)
- EGVFVSNGTHWFVTQR (16aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQK (32aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQKE (33aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- NHTSPDVDLGDISGINASVVNIQKE (25aa)
- VAKNLNESLIDLQE (14aa)
-
- Hex:2 HexNAc:2 / N-Linked
(avg mass : 748.6901)
- BTI-Tn-5B1-4 (CVCL_C190)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Unreviewed
- Identification of 22 N-glycosites on spike glycoprotein of SARS-CoV-2 and accessible surface glycopeptide motifs: Implications for vaccination and antibody therapeutics (2020 - Dapeng Zhou, Xiaoxu Tian, Ruibing Qi, Chao Peng, Wen Zhang) / Status : Reviewed
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKR (34aa)
- HAIHVSGTNGTK (12aa)
- LIVNNATNVVIK (12aa)
- IVNNATNVVIK (11aa)
- TQSLLIVNNATNVVIK (16aa)
- VYSSANNCTFE (11aa)
- SEFRVYSSANNCTFE (15aa)
- NGTITDAVDCALDPLSE (17aa)
- FPNITNLCPFGE (12aa)
- VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
- GEVFNATR (8aa)
- CPFGEVFNATR (11aa)
- QDVNCTEVPVAIHADQLTPTWR (22aa)
- ILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWR (51aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- TPPIKDFGGFNFSQILPDPSKPSKR (25aa)
- VFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIE (39aa)
- DFGGFNFSQILPDPSKPSKR (20aa)
- DFGGFNFSQILPDPSKPSK (19aa)
- DFGGFNFSQILPDPSK (16aa)
- NFSQILPDPSK (11aa)
- VPAQEKNF (8aa)
- VPAQEKNFTTAPAICHDGK (19aa)
- KNFTTAPAICHDGK (14aa)
- GVFVSNGTHWFVTQR (15aa)
- GYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGK (41aa)
- VSNGTHWF (8aa)
- EGVFVSNGTHW (11aa)
- EGVFVSNGTHWF (12aa)
- NFTTAPAICHDGK (13aa)
- EGVFVSNGTHWFVTQR (16aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQKE (33aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- VAKNLNESLIDLQE (14aa)
-
- Hex:1 HexNAc:2 dHex:2 / N-Linked
(avg mass : 878.8337)
- BTI-Tn-5B1-4 (CVCL_C190)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKR (34aa)
- VYSSANNCTFE (11aa)
- SEFRVYSSANNCTFE (15aa)
- VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- DFGGFNFSQILPDPSKPSK (19aa)
- KNFTTAPAICHDGK (14aa)
- GYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGK (41aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQK (32aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQKE (33aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- YFKNHTSPDVDLGDISGINASVVNIQK (27aa)
- YFKNHTSPDVDLGDISGINASVVNIQKE (28aa)
- NHTSPDVDLGDISGINASVVNIQKE (25aa)
- VAKNLNESLIDLQE (14aa)
-
- Hex:2 HexNAc:2 dHex:1 / N-Linked
(avg mass : 894.8331)
- BTI-Tn-5B1-4 (CVCL_C190)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Unreviewed
- Identification of 22 N-glycosites on spike glycoprotein of SARS-CoV-2 and accessible surface glycopeptide motifs: Implications for vaccination and antibody therapeutics (2020 - Dapeng Zhou, Xiaoxu Tian, Ruibing Qi, Chao Peng, Wen Zhang) / Status : Reviewed
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- FSNVTWF (7aa)
- SNVTWF (6aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- FHAIHVSGTNGTK (13aa)
- FHAIHVSGTNGTKR (14aa)
- HAIHVSGTNGTKR (13aa)
- HAIHVSGTNGTK (12aa)
- LIVNNATNVVIK (12aa)
- IVNNATNVVIK (11aa)
- TQSLLIVNNATNVVIK (16aa)
- FQFCNDPFLGVYYHKNNK (18aa)
- VYSSANNCTFE (11aa)
- SEFRVYSSANNCTFE (15aa)
- SSANNCTF (8aa)
- NGTITDAVDCALDPLSE (17aa)
- YNENGTITDAVDCALDPLSETK (22aa)
- FPNITNLCPF (10aa)
- SIVRFPNITNLCPFGE (16aa)
- FPNITNLCPFGE (12aa)
- FPNITNL (7aa)
- VFNATR (6aa)
- FPNITNLCPFGEVFNATR (18aa)
- GEVFNATR (8aa)
- CPFGEVFNATR (11aa)
- QDVNCTEVPVAIHADQLTPTWR (22aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRR (37aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRRAR (39aa)
- AGCLIGAEHVNNSYE (15aa)
- HVNNSYECDIPIGAGICASYQTQTNSPR (28aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
Source
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
- Hex:2 HexNAc:2 dHex:1 / N-Linked
(avg mass : 894.8331)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:1 HexNAc:2 dHex:2 / N-Linked
(avg mass : 878.8337)
Source
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
- Hex:2 HexNAc:2 / N-Linked
(avg mass : 748.6901)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:1 HexNAc:2 dHex:1 / N-Linked
(avg mass : 732.6907)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- HexNAc:2 dHex:2 / N-Linked
(avg mass : 716.6913)
Source
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
- Hex:1 HexNAc:2 / N-Linked
(avg mass : 586.5477)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- HexNAc:2 dHex:1 / N-Linked
(avg mass : 570.5483)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- HexNAc:1 dHex:2 / N-Linked
(avg mass : 513.4963)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- HexNAc:2 / N-Linked
(avg mass : 424.4053)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- HexNAc:1 dHex:1 / N-Linked
(avg mass : 367.3533)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- HexNAc:1 / N-Linked
(avg mass : 221.2103)
Disease
Reported glycosite
Mass spectrometry observed peptide
- O-Linked / Core 1
(avg mass : 383.3527)
Disease
Reported glycosite
Mass spectrometry observed peptide
- O-Linked / Core 0
(avg mass : 221.2103)